Williams Brinkley Ruth
Travere Therapeutics, Inc. · Director
Williams Brinkley Ruth is listed in filings as Director at Travere Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including 6 public disclosures. Recent filings connect the profile to Travere Therapeutics, Inc. (TVTX) and Natera Inc (NTRA). The current snapshot covers public activity from May 16, 2025 to May 21, 2026. Reported amounts are shown as $507.1K to $412.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||